Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD

Affiliations

Hiroyuki Suzuki: Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
Shigeo Shimose: Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
Hideki Iwamoto: Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
Takashi Niizeki: Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
Takumi Kawaguchi: Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Abstract

No abstracts available.

ISSN: 2287-2728 (Print); 2287-285X (Online)
Publisher: Korean Association for the Study of the Liver
Country of publisher: Korea, Republic of
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: http://www.e-cmh.org